49
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Micropulse Transscleral Cyclophotocoagulation in Non-Incisional Eyes with Ocular Hypertension and Primary Open-Angle Glaucoma

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon &
Pages 1295-1312 | Received 02 Nov 2023, Accepted 08 Apr 2024, Published online: 11 May 2024

References

  • Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017;390(10108):2183–2193. doi:10.1016/S0140-6736(17)31469-1
  • Miglior S, Zeyen T, Pfeiffer N, et al. Results of the European glaucoma prevention study. Ophthalmology. 2005;112(3):366–375. doi:10.1016/j.ophtha.2004.11.030
  • Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701–830. doi:10.1001/archopht.120.6.701
  • Leske MC, Heijl A, Hyman L, Bengtsson B. Early manifest glaucoma trial: design and baseline data. Ophthalmology. 1999;106(11):2144–2153. doi:10.1016/s0161-6420(99)90497-9
  • The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators Am J Ophthalmol. 2000;130(4):429–440. doi:10.1016/S0002-9394(00)00538-9
  • Sanchez FG, Peirano-Bonomi JC, Brossard Barbosa N, Khoueir Z, Grippo TM. Update on micropulse transscleral cyclophotocoagulation. J Glaucoma. 2020;29(7):598–603. doi:10.1097/IJG.0000000000001539
  • Pastor SA, Singh K, Lee DA, et al. Cyclophotocoagulation: a report by the American Academy of ophthalmology. Ophthalmology. 2001;108(11):2130–2138. doi:10.1016/s0161-6420(01)00889-2
  • Moussa K, Feinstein M, Pekmezci M, et al. Histologic changes following continuous wave and micropulse transscleral cyclophotocoagulation: a randomized comparative study. Transl Vis Sci Technol. 2020;9(5):22. doi:10.1167/tvst.9.5.22
  • Maslin JS, Chen PP, Sinard J, Nguyen AT, Noecker R. Histopathologic changes in cadaver eyes after MicroPulse and continuous wave transscleral cyclophotocoagulation. Can J Ophthalmol. 2020;55(4):330–335. doi:10.1016/j.jcjo.2020.03.010
  • Sanchez FG, Peirano-Bonomi JC, Grippo TM. Micropulse Transscleral Cyclophotocoagulation: a Hypothesis for the Ideal Parameters. Med Hypothesis Discov Innov Ophthalmol. 2018;7(3):94–100.
  • Aquino MC, Barton K, Tan AM, et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol. 2015;43(1):40–46. doi:10.1111/ceo.12360
  • Souissi S, Le Mer Y, Metge F, et al. An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma. Acta Ophthalmol. 2021;99(5):e621–e653. doi:10.1111/aos.14661
  • Wong KYT, Aquino CM, Macasaet AM, Suwandono ME, Chew PTK, Koh VTC. MP3 Plus: a modified micropulse transscleral cyclophototherapy technique for the treatment of refractory glaucoma. J Glaucoma. 2020;29(4):264–270. doi:10.1097/IJG.0000000000001443
  • Williams AL, Moster MR, Rahmatnejad K, et al. Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma. 2018;27(5):445–449. doi:10.1097/IJG.0000000000000934
  • Vig N, Ameen S, Bloom P, et al. Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma. Graefes Arch Clin Exp Ophthalmol. 2020;258(5):1073–1079. doi:10.1007/s00417-020-04611-0
  • Tekeli O, Köse HC. Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma. Eur J Ophthalmol. 2021;31(3):1113–1121. doi:10.1177/1120672120914231
  • Emanuel ME, Grover DS, Fellman RL, et al. Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma. 2017;26(8):726–729. doi:10.1097/IJG.0000000000000715
  • Canadian Ophthalmological Society Glaucoma Clinical Practice Guideline Expert Committee; Canadian Ophthalmological Society. Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye. Can J Ophthalmol. 2009;44:S7–S93. doi:10.3129/cjo44s1
  • Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M. Resolving the clinical acuity categories ”hand motion” and ”counting fingers” using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247(1):137–142. doi:10.1007/s00417-008-0926-0
  • Kaba Q, Somani S, Tam E, Yuen D. The effectiveness and safety of micropulse cyclophotocoagulation in the treatment of ocular hypertension and glaucoma. Ophthalmol Glaucoma. 2020;3(3):181–189. doi:10.1016/j.ogla.2020.02.005
  • Al Habash A, AlAhmadi AS. Outcome of microPulse® transscleral photocoagulation in different types of glaucoma. Clin Ophthalmol. 2019;13:2353–2360. doi:10.2147/OPTH.S226554
  • Yelenskiy A, Gillette TB, Arosemena A, et al. Patient outcomes following micropulse transscleral cyclophotocoagulation: intermediate-term results. J Glaucoma. 2018;27(10):920–925. doi:10.1097/IJG.0000000000001023
  • Tong W, Shen TYT, Wong HC, Aquino MC, Chew P, Lim D. One-year outcomes of micropulse cyclophototherapy for primary open-angle glaucoma. J Glaucoma. 2021;30(10):911–920. doi:10.1097/IJG.0000000000001925
  • Waibel S, Herber R, Pillunat LE, Pillunat KR. One-year follow-up of pars plicata versus pars plana application of transscleral micropulse cyclophotocoagulation. J Glaucoma. 2021;30(4):340–346. doi:10.1097/IJG.0000000000001775
  • Balendiran V, Landreneau J, An J. MicroPulse transscleral laser therapy dosimetry utilizing the revised P3 delivery device: a randomized controlled trial. Ophthalmol Glaucoma. 2022;S2589–4196(22):189. doi:10.1016/j.ogla.2022.09.004
  • Daas A, Sherman T, Danieliute L, et al. Phacoemulsification combined with micropulse cyclodiode laser in glaucoma patients: efficacy and safety. Eye. 2022;36(11):2188–2191. doi:10.1038/s41433-021-01826-1
  • Fili S, Vastardis I, Perdikakis G, Kohlhaas M. Transscleral cyclophotocoagulation with MicroPulse® laser versus cyclophotocoagulation with continuous diode laser in patients with open-angle glaucoma. Int Ophthalmol. 2022;42(2):525–539. doi:10.1007/s10792-021-02023-5
  • Sarrafpour S, Saleh D, Ayoub S, Radcliffe NM. Micropulse transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes. Ophthalmol Glaucoma. 2019;2(3):167–171. doi:10.1016/j.ogla.2019.02.002
  • Preda MA, Karancsi OL, Munteanu M, Stanca HT. Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma-18 months follow-up. Lasers Med Sci. 2020;35(7):1487–1491. doi:10.1007/s10103-019-02934-x
  • De Keyser M, De Belder M, De Belder S, De Groot V. Where does selective laser trabeculoplasty stand now? A review. Eye Vis (Lond). 2016;3:10. doi:10.1186/s40662-016-0041-y
  • Marchand M, Singh H, Agoumi Y. Micropulse trans-scleral laser therapy outcomes for uncontrolled glaucoma: a prospective 18-month study. Can J Ophthalmol. 2021;56(6):371–378. doi:10.1016/j.jcjo.2021.01.015
  • Grippo TM, Sanchez FG, Stauffer J, Marcellino G. MicroPulse® transscleral laser therapy - fluence may explain variability in clinical outcomes: a literature review and analysis. Clin Ophthalmol. 2021;15:2411–2419. doi:10.2147/OPTH.S313875
  • de Crom RMPC, Slangen CGMM, Kujovic-Aleksov S, Webers CAB, Berendschot TTJM, Beckers HJM. Micropulse transscleral cyclophotocoagulation in patients with glaucoma: 1- and 2-year treatment outcomes. J Glaucoma. 2020;29(9):794–798. doi:10.1097/IJG.0000000000001552
  • Garcia GA, Nguyen CV, Yelenskiy A, et al. Micropulse transscleral diode laser cyclophotocoagulation in refractory glaucoma: short-term efficacy, safety, and impact of surgical history on outcomes. Ophthalmol Glaucoma. 2019;2(6):402–412. doi:10.1016/j.ogla.2019.08.009
  • Tan AM, Chockalingam M, Aquino MC, Lim ZI, See JL, Chew PT. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Exp Ophthalmol. 2010;38(3):266–272. doi:10.1111/j.1442-9071.2010.02238.x
  • Xu H, Lee D, Cho J, Voss J, McDaniel L, An JA. Netarsudil as a predictor of response for micropulse transscleral laser therapy: a pilot study. Ophthalmol Glaucoma. 2022;5(6):658–662. doi:10.1016/j.ogla.2022.06.005
  • Souissi S, Baudouin C, Labbé A, Hamard P. Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction. Eur J Ophthalmol. 2021;31(1):112–119. doi:10.1177/1120672119877586
  • Varikuti VNV, Shah P, Rai O, et al. Outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision. J Glaucoma. 2019;28(10):901–905. doi:10.1097/IJG.0000000000001339
  • Rotchford AP, Jayasawal R, Madhusudhan S, Ho S, King AJ, Vernon SA. Transscleral diode laser cycloablation in patients with good vision. Br J Ophthalmol. 2010;94(9):1180–1183. doi:10.1136/bjo.2008.145565
  • Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL. Treatment outcomes in the tube versus trabeculectomy study after one year of follow-up. Am J Ophthalmol. 2007;143(1):9–22. doi:10.1016/j.ajo.2006.07.020
  • Patel HY, Danesh-Meyer HV. Incidence and management of cataract after glaucoma surgery. Curr Opin Ophthalmol. 2013;24(1):15–20. doi:10.1097/ICU.0b013e32835ab55f
  • Phulke S, Kaushik S, Kaur S, Pandav SS. Steroid-induced glaucoma: an avoidable irreversible blindness. J Curr Glaucoma Pract. 2017;11(2):67–72. doi:10.5005/jp-journals-l0028-1226
  • Perez CI, Han Y, Rose-Nussbaumer J, Ou Y, Hsia YC. Neurotrophic keratitis after micropulse transscleral diode laser cyclophotocoagulation. Am J Ophthalmol Case Rep. 2019;15:100469. doi:10.1016/j.ajoc.2019.100469
  • Radhakrishnan S, Wan J, Tran B, et al. Micropulse cyclophotocoagulation: a multicenter study of efficacy, safety, and factors associated with increased risk of complications. J Glaucoma. 2020;29(12):1126–1131. doi:10.1097/IJG.0000000000001644
  • Nijm LM, De Benito-Llopis L, Rossi GC, Vajaranant TS, Coroneo MT. Understanding the dual dilemma of dry eye and glaucoma: an international review. Asia Pac J Ophthalmol. 2020;9(6):481–490. doi:10.1097/APO.0000000000000327
  • Vieira GM, Vieira FJ, Ritch R. Urrets-zavalia syndrome after diode laser transscleral cyclophotocoagulation. J Glaucoma. 2017;26(7):678–682. doi:10.1097/IJG.0000000000000666
  • Egbert PR, Fiadoyor S, Budenz DL, Dadzie P, Byrd S. Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for primary open-angle glaucoma. Arch Ophthalmol. 2001;119(3):345–350. doi:10.1001/archopht.119.3.345
  • Nguyen AT, Maslin J, Noecker RJ. Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma. Eur J Ophthalmol. 2020;30(4):700–705. doi:10.1177/1120672119839303